ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/056/SRR17838956/SRR17838956_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/058/SRR17838958/SRR17838958_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17838960/SRR17838960_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17838954/SRR17838954_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17838952/SRR17838952_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/057/SRR17838957/SRR17838957_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17838954/SRR17838954_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17838960/SRR17838960_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17838951/SRR17838951_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17838952/SRR17838952_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17838955/SRR17838955_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17838951/SRR17838951_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/057/SRR17838957/SRR17838957_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/058/SRR17838958/SRR17838958_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17838953/SRR17838953_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/059/SRR17838959/SRR17838959_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17838955/SRR17838955_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/059/SRR17838959/SRR17838959_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17838953/SRR17838953_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/056/SRR17838956/SRR17838956_1.fastq.gzprimaryOK200GenomicsBermick, Pediatrics, University of Iowahttps://www.ebi.ac.uk/ena/browser/view/PRJNA802253Homo sapiensATAC-seq analysis of human cord blood monocytes display sex-associated differences in chromatin landscape with female-derived monocytes having more accessibility in type-1 immune genes. Overall design: Chromatin accessibilty assessed by ATAC-seq in umbilical cord blood CD14+ monocytesENAGene., Controlling, lifespan, preventive therapy, Innate Immunity, Natural Immunity, Immunity, nonspecific immune response, Native, A4, innate immunity, Gene, IFNA@, TYPE, prevention, Fs(3)Sz11, LGMD2C, DAGA4, IFNA13, Resistance, DmF2, MAM, Fs(3)Hor, prevention and control, SCG3, lod, Genotypic, DmelCG2684, Immune Responses, Native Immunity, Sex, Genotypic Sex, Gene Expressions, reference sample, DMDA1, IFN-alphaD, Epigenetic, entire lifespan, Natural, entire life cycle, prophylaxis, life, IFL, IFN, NTef2, Innate Immune Responses, Lds, Natural Resistance, Expressions, Phenotypic, early, Non-Specific Immunity, Epigenomic, Innate Immune Response, preventive measures, Immune Response, DMDA, sex, control, Phenotypic Sex, Horka, Non-Specific, SCARMD2, CG2684, Fs(3)Horka, Expression, associated, Epigenetics, Innate, Non Specific, Controlled, IFN-ALPHAGene., Controlling, lifespan, preventive therapy, Innate Immunity, Natural Immunity, Immunity, nonspecific immune response, Native, A4, innate immunity, Gene, IFNA@, TYPE, prevention, Fs(3)Sz11, LGMD2C, DAGA4, IFNA13, Resistance, DmF2, MAM, Fs(3)Hor, prevention and control, SCG3, lod, Genotypic, DmelCG2684, Immune Responses, Native Immunity, Sex, Genotypic Sex, Gene Expressions, reference sample, DMDA1, IFN-alphaD, Epigenetic, entire lifespan, Natural, entire life cycle, prophylaxis, life, IFL, IFN, NTef2, Innate Immune Responses, Lds, Natural Resistance, Expressions, Phenotypic, early, Non-Specific Immunity, Epigenomic, Innate Immune Response, preventive measures, Immune Response, DMDA, sex, control, Phenotypic Sex, Horka, Non-Specific, SCARMD2, CG2684, Fs(3)Horka, Expression, associated, Epigenetics, Innate, Non Specific, Controlled, IFN-ALPHAfalseSex-associated Early-life Innate Immune Response is Transcriptionally Regulated by Epigenetic Control of Type-I IFN-inducible Gene ExpressionSex-associated Early-life Innate Immune Response is Transcriptionally Regulated by Epigenetic Control of Type-I IFN-inducible Gene Expression2025-09-242022-02-05PRJNA802253GSE1958369606